Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.
Stein
G E
GE
Department of Medicine, Michigan State University, East Lansing, MI 48824, USA. steing@msu.edu
El-Mortada
M
M
Smith
C
C
Dybas
L
L
Prince
R
R
Havlichek
D
D
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000077612:Anidulafungin; D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy / Q000382:microbiology*; D015169:Colony Count, Microbial; D054714:Echinocandins / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D016469:Fungemia / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008297:Male; D050296:Microbial Viability / Q000187:drug effects*; D008875:Middle Aged; D044967:Serum / Q000382:microbiology*; D055815:Young Adult
D000935:Antifungal Agents; D054714:Echinocandins; D000077612:Anidulafungin